Wall Street analyst estimates for Sight Sciences, Inc. (SGHT): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult glaucoma patients.
Valuation Ratios
| Price / Book | 8.43 |
| EV / EBITDA | -15.74 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5M | $23.3M | $27.6M | $49.0M | $71.3M | $81.1M | $79.9M | $77.4M |
| Cost of Revenue | $2.3M | $6.5M | $9.2M | $8.6M | $12.4M | $11.9M | $11.6M | $10.7M |
| Gross Profit | $5.2M | $16.8M | $18.4M | $40.3M | $59.0M | $69.2M | $68.3M | $66.7M |
| Research & Development | $5.4M | $8.1M | $8.9M | $15.6M | $22.9M | $17.6M | $18.0M | $14.6M |
| Selling, General & Admin | $14.1M | $32.7M | $41.7M | $76.2M | $120.1M | $108.9M | $100.8M | $89.2M |
| Operating Expenses | $19.5M | $40.8M | $50.6M | $91.8M | $142.9M | $126.4M | $118.8M | $103.8M |
| Operating Income | -$14.3M | -$24.0M | -$32.2M | -$51.5M | -$84.0M | -$57.3M | -$50.5M | -$37.1M |
| EBITDA | -$14.2M | -$23.5M | -$31.7M | -$57.2M | -$80.5M | -$49.4M | -$45.9M | -$32.8M |
| Interest Expense | 0 | $2.0M | $2.4M | $4.4M | $4.5M | $5.4M | $4.7M | $5.1M |
| Pre-tax Income | -$14.3M | -$25.9M | -$34.6M | -$62.8M | -$86.2M | -$55.4M | -$51.3M | -$38.4M |
| Income Tax | -$6000 | $8000 | $61000 | $188000 | $47000 | $110000 | $236000 | $10000 |
| Net Income | -$14.3M | -$25.9M | -$34.7M | -$63.0M | -$86.2M | -$55.5M | -$51.5M | -$38.4M |
| EPS | $-0.44 | $-0.55 | $-0.74 | $-1.33 | $-1.80 | $-1.14 | $-1.03 | $-0.74 |
| EPS (Diluted) | $-0.44 | $-0.77 | $-0.74 | $-1.33 | $-1.80 | $-1.14 | $-1.03 | $-0.74 |
| Shares Outstanding (Diluted) | $32.2M | $33.6M | $46.8M | $47.5M | $47.8M | $48.6M | $50.1M | $52.1M |
Price
| Price | $8.14 |
| Market Cap | $443M |
| Exchange | NASDAQ |
| Country | US |
Related companies: CERS · CVRX · LFCR · MASS · OMI · PRQR · QTRX
Explore sector: Healthcare · Medical - Devices
More sections of SGHT: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks